SCHEMBL979452

SCHEMBL979452

O=C(Cc1ccc2nsnc2c1)N1CCC(c2cccc(Cl)c2)=N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 3/20 0.41
ORAI1 Q96D31 3/20 0.41
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
PKM P14618 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MET P08581 1/20 0.39
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
SAE1 Q9UBE0 1/20 0.37
UBA2 Q9UBT2 1/20 0.37
CYP2C9 P11712 1/20 0.36
HCRTR1 O43613 1/20 0.36
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980254 0.89 PGR (0.46) PGRALDH1A1LMNAPKMNPSR1
SCHEMBL984420 0.88 HCRTR1 (0.45) PGRALDH1A1LMNAPKMCYP1A2
SCHEMBL17004388 0.88 GRM5 (0.39) PGRALDH1A1KDM4EHCRTR1CHRNB4
SCHEMBL982372 0.84 MET (0.50) PGRORAI1ALDH1A1LMNAMET
SCHEMBL980719 0.83 ALDH1A1 (0.42) PGRALDH1A1LMNANPSR1MAPT
SCHEMBL981003 0.83 MET (0.42) PGRORAI1ALDH1A1LMNANPSR1
SCHEMBL979962 0.82 ORAI1 (0.57) PGRORAI1ALDH1A1LMNAPKM
SCHEMBL979329 0.82 ALDH1A1 (0.37) PGRALDH1A1LMNANPSR1MAPT
SCHEMBL979417 0.82 MAOB (0.43) PGRALDH1A1LMNAMAPTPOLB
SCHEMBL981273 0.82 PGR (0.42) PGRALDH1A1MAPTKDM4EHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917248-B1 1-ACYLDIHYDROPYRAZOL DERIVATIVES MERCK PATENT GMBH (DE) 2015-08-19 EP claimed
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MERCK PATENT GESELLSCHAFT (DE) 2008-10-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MET, FLT3, ERBB3 PGR 1338/4885ORAI1 4824/4885ALDH1A1 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.